Sleep Apnea Severity Linked to Glycated Hemoglobin Levels

For adults without diabetes, OSA severity independently linked to impaired glucose metabolism

MONDAY, June 18 (HealthDay News) -- For adults without diabetes, obstructive sleep apnea (OSA) severity is independently associated with impaired glucose metabolism, as measured by glycated hemoglobin (HbA1c) levels, according to a study published online June 11 in Diabetes Care.

Pascaline Priou, M.D., of LUNAM University in Angers, France, and colleagues conducted a large cross-sectional study involving 1,599 patients with OSA. HbA1c levels were measured, and patients with diabetes, use of diabetes medications, or HbA1c levels ≥6.5 percent were excluded.

The researchers found that HbA1c levels increased with increasing OSA severity, as measured by the apnea-hypopnea index (AHI), with the percent of patients with HbA1c increasing from 10.8 to 34.2 percent for those with AHI values <5 to ≥50, respectively. After adjusting for potential confounding factors, the odds ratios of a patient having an HbA1c level >6.0 percent increased from 1.0 (reference) for AHI <5; to 1.40 for AHI of ≥5 to <15; to 1.8 for AHI of ≥15 to <30; to 2.02 for AHI of ≥30 to <50; to 2.96 for AHI of ≥50. Additionally, an independent association was found between increasing hypoxemia during sleep and the odds of an elevated HbA1c level.

"Among adults without known diabetes, increasing OSA severity is independently associated with impaired glucose metabolism, as assessed by higher HbA1c values, which may expose them to higher risks of diabetes and cardiovascular disease," the authors write.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles

Debunking Three Rape Myths
Journal of Forensic Nursing, October/December 2014
Expires: 12/31/2016 CE:2.5 $24.95


Drug updates and approvals: 2014 in review
The Nurse Practitioner, 13December 2014
Expires: 12/31/2016 CE:3 $27.95


Can Food Processing Enhance Cancer Protection?
Nutrition Today, September/October 2014
Expires: 10/31/2016 CE:2 $21.95


More CE Articles

Subscribe to Recommended CE

Recommended Nursing Articles Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events